What can functional brain imaging teach us about remission of type 2 diabetes? Hirani D, Alabdulkader S, Miras AD, Salem V. What can functional brain imaging teach us about remission of type 2 diabetes? Diabet Med Insulin Resistance & Diabetes
Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population Buckley A, Suliman S, Allum M, Mohammed N, Lessan N, le Roux CW, Suliman M. Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population Diabetes Obes Metab Insulin Resistance & Diabetes
Women’s perspectives on mHealth behavior change interventions for the management of overweight, obesity, or gestational diabetes: A qualitative meta-synthesis McGovern L, O'Toole L, Houshialsadat Z, O'Reilly SL. Women’s perspectives on mHealth behavior change interventions for the management of overweight, obesity, or gestational diabetes: A qualitative meta-synthesis Obes Rev Insulin Resistance & Diabetes
Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus Anyiam O, Phillips B, Quinn K, Wilkinson D, Smith K, Atherton P, Idris I. Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus Clin Nutr Insulin Resistance & Diabetes
Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes Al-Ozairi E, Irshad M, AlKandari J, Mashankar A, Alroudhan D, le Roux CW. Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes Diabetes Obes Metab Insulin Resistance & Diabetes
Postnatal Cardiometabolic Health After Metformin Use in Gestational Diabetes: A Secondary Analysis of the EMERGE Trial Dunne F, Newman C, Alvarez-Iglesias A, O'Shea P, Devane D, Gillespie P, Egan A, Donnell MO, Smyth A. Postnatal Cardiometabolic Health After Metformin Use in Gestational Diabetes: A Secondary Analysis of the EMERGE Trial J Clin Endocrinol Metab Insulin Resistance & Diabetes
Serum IL-36β levels are associated with Insulin sensitivity in paediatric patients with obesity Narros-Fernández P, O'Donnell A, Sheehy C, Basavarajappa SC, Hernandez Santana YE, Kinlen D, Cody D, Hogan AE, Walsh PT. Serum IL-36β levels are associated with Insulin sensitivity in paediatric patients with obesity Int J Obes (Lond) Insulin Resistance & Diabetes
NPYR modulation: Potential for the next major advance in obesity and type 2 diabetes management? Lafferty RA, Flatt PR, Irwin N. NPYR modulation: Potential for the next major advance in obesity and type 2 diabetes management? Peptides Insulin Resistance & Diabetes
Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes? Lafferty RA, Flatt PR, Gault VA, Irwin N. Does glucose-dependent insulinotropic polypeptide receptor blockade as well as agonism have a role to play in management of obesity and diabetes? J Endocrinol Insulin Resistance & Diabetes
The double burden: Navigating type 1 diabetes and obesity Steenackers N, Feldman AN, Mathieu C, Rosen J, Soderberg J, Al-Ozairi E, le Roux CW, Van der Schueren B. The double burden: Navigating type 1 diabetes and obesity Clin Obes Insulin Resistance & Diabetes